CAS: 926927-61-9; 2-Amino-N,N-Dipropyl-8-(4-(Pyrrolidine-1-Carbonyl)Phenyl)-3H-Benzo[b]Azepine-4-Carboxamide

该化合物是一个小分子,主要因其在肿瘤学和免疫学方面的潜在治疗应用而接受调查,它的作用是作为类似收费的受体8 (TLR8) 激动剂,这意味着它可以通过激活TLR8来刺激免疫系统,一种在免疫反应中发挥关键作用的受体.这种激活可以提高身体识别和抗击癌症细胞的能力,并可能对治疗病毒感染产生影响.VTX-2337的特点是它能够诱导细胞生产,从而导致免疫反应的改善.该化合物在各种临床前和临床环境中进行了研究,以评估其功效和安全性.其化学结构和特性有助于其生物活动,使其成为旨在利用免疫系统获取治疗利益的药物开发的一个主题.目前正在进行进一步的研究,以充分了解其机制及其在临床实践中的潜在应用.

结构式图片

上下游产品

(Tert-Butoxy)-N-{4-(N,N-Dipropylcarbamoyl)-8-[4-(Pyrrolidinylcarbonyl)Phenyl](3H-Benzo[f]Azepin-2-yl)}Carboxamide 1226791-83-8

合成工艺路线路线简述

  • 926927-54-0 = 926927-61-9
    反应条件:1.1 Reagents: Trimethylaluminum Solvents: Toluene; 10 Min,Rt1.2 Rt -> 75 °C; 16 - 20 H,75 °C; Cooled1.3 Reagents: Potassium Sodium Tartrate; 20 Min
    标题:8-Substituted Benzazepines As Toll-Like Receptor Modulators,Their Preparation,Pharmaceutical Compositions,And Use In Therapy
    参考文献:World Intellectual Property Organization]

    389621-81-2 + 1226791-82-7 = 926927-61-9
    反应条件:1.1 Reagents: Sodium Carbonate Catalysts: Palladium Diacetate,Bis(P-Sulfonatophenyl)Phenylphosphine Dihydrate Dipotassium Salt Solvents: Ethanol; 30 Min,Rt; Rt -> 78 °C; 4 H,75 - 78 °C1.2 Reagents: Trifluoroacetic Acid Solvents: Dichloromethane,Cyclohexane; -25 °C; 30 Min,-25 - -20 °C; Overnight,-20 °C -> 25 °C1.3 Reagents: Sodium Bicarbonate Solvents: Water; Basified
    标题:Preparation Of Benzo[b]Azepine-4-Carboxamides
    参考文献:World Intellectual Property Organization]

    = 926927-61-9 [标题:Reaction Conditions
    标题:8-Substituted Benzoazepines As Toll-Like Receptor Modulators
    参考文献:United States
(Tert-Butoxy)-N-{4-(N,N-Dipropylcarbamoyl)-8-[4-(Pyrrolidinylcarbonyl)Phenyl](3H-Benzo[f]Azepin-2-yl)}Carboxamide置于三氟乙酸,碳酸氢钠体系中,用 二氯甲烷,水 作为反应溶剂,以92.3%的收率获得产物motolimod(莫托莫德)
参考文献: Methods Of Synthesis Of Benzazepine Derivatives[fr] Procédés De Synthèse De Dérivés De Benzazépine
标题: Methods Of Synthesis Of Benzazepine Derivatives[fr] Procédés De Synthèse De Dérivés De Benzazépine
摘要:该披露描述了合成取代苯并哌啶衍生物的方法.根据该披露的首选方法,允许大规模制备低金属杂质水平的苯并哌啶化合物.在某些实施例中,根据该披露的首选方法还可以在比先前用于制备这类化合物的方法更高的产率下制备苯并哌啶衍生物,而无需使用色谱纯化方法.本披露的方法在合成有机化学和药物化学中具有实用性.

海关参考信息

专利信息


专利号:US-8314090-B2
优先权日:2008-11-06
标 题:Methods of synthesis of benzazepine derivatives
发明人:HOWBERT J JEFFRY; KUSUKUNTLA VENKAT REDDY; TRETYAKOV ALEXANDER; NIELSEN NATHAN; KRASIK PAVEL; JIANG JI-LONG; YANG HONG WOON
权利人:HOWBERT J JEFFRY; KUSUKUNTLA VENKAT REDDY; TRETYAKOV ALEXANDER; NIELSEN NATHAN; KRASIK PAVEL; JIANG JI-LONG; YANG HONG WOON; VENTIRX PHARMACEUTICALS INC; ARRAY BIOPHARMA INC
摘要:The disclosure describes method of synthesis of substituted benzazepine derivatives. Preferred methods according to the disclosure allow for large-scale preparation of benzazepine compounds having low levels of metal impurities. In some embodiments, preferred methods according to the disclosure also allow for the preparation of benzazepine derivatives without the use of chromatographic purification methods and in better yield than previously used methods for preparing such compounds. The methods disclosed herein find utility in synthetic organic chemistry as well as medicinal chemistry.

专利号:US-2022233673-A1
优先权日:2019-06-04
标 题:METHODS OF PRODUCING SHIGA TOXIN B-SUBUNIT (STxB) MONOMERS AND OLIGOMERS, AND USES THEREOF
发明人:BILLET ANNE; SCHMIDT FRÉDÉRIC; JOHANNES LUDGER; SERVENT DENIS; MOURIER GILLES; TARTOUR ÉRIC; KAY MICHAEL; FULCHER JAMES M
权利人:INST CURIE; CENTRE NAT RECH SCIENT; INST NAT SANTE RECH MED; COMMISSARIAT A LENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES CEA; APHP ASSIST PUBLIQUE HOPITAUX DE PARIS; UNIV PARIS; UNIV OF UTAH RESEARCH FOUDATION; UNIV UTAH RES FOUND
摘要:A method of producing a monomer of a Shiga toxin B-subunit (STxB) protein or of a variant thereof by peptide chemical synthesis, as well as to a method of producing a pentamer of the STxB protein or of the variant thereof. The methods are particularly advantageous as they overcome major issues typically observed in peptide chemical synthesis, including solubility and purity issues.

专利号:US-2022259212-A1
优先权日:2019-07-11
标题:Inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan 2,3-dioxygenase
发明人:BOSS CHRISTOPH; CREN SYLVAINE; KIMMERLIN THIERRY; LOTZ-JENNE CARINA; POTHIER JULIEN; TIDTEN-LUKSCH NAOMI
权利人:IDORSIA PHARMACEUTICALS LTD
摘要:The present invention relates to compounds of Formula (I) inhibiting indoleamine 2,3-dioxygenase (IDO) and/or tryptophan 2,3-dioxygenase (TDO) enzymes. Further, their synthesis and their use as medicaments in the treatment of inter alia cancer is disclosed.

专利号:ES-2705101-T3
优先权日:2008-11-06
标 题:Methods of synthesis of benzazepine derivatives

专利号:CA-2742863-C
优先权日:2008-11-06
标题 :Methods of synthesis of benzazepine derivatives

专利号:AU-2009313392-B2
优先权日:2008-11-06
标题 :Methods of synthesis of benzazepine derivatives
上海兴默生物技术有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.xmobio.com
电话: 0086 13524779951; 13524779951👤
📞上海兴默生物技术有限公司 ⚠️参考联系方式

销售电话:0086 13524779951; 13524779951
邮箱:sales@xmobio.com
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

主要参考文献


1: Yang W, Sun X, Liu S, Xu Y, Li Y, Huang X, Liu K, Mao L, Min S, Liu L, Li S, Zhu Y, Zhang Y, Xie X, Xu K, Sun C, Yan J, Li Z. TLR8 agonist Motolimod-induced inflammatory death for treatment of acute myeloid leukemia. Biomed Pharmacother. 2023 Jul;163:114759. doi: 10.1016/j.biopha.2023.114759. Epub 2023 Apr 25.
179:112987. doi: 10.1016/j.jpba.2019.112987. Epub 2019 Nov 12.
167:90-99. doi: 10.1016/j.jpba.2019.02.009. Epub 2019 Feb 7. 4(11):1583-1588. doi: 10.1001/jamaoncol.2018.1888.

合成参考文献


参考文献:10.1007/s00106-015-0076-8
摘要:Kansy B, Hussain T, Mattheis S, Wollenberg B, Brandau S, Lang S. [Immunotherapy in head and neck cancer]. HNO. 2015 Nov;63(11):797–803. doi: 10.1007/s00106-015-0076-8.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知